Search company, investor...


Merger | Merged

About ProTrans

ProTrans is one of the premier transportation Wholesalers and Program Managers in the US. ProTrans offers the finest-quality insurance coverage for private school bus operators, motor coach operators, the limousine/black car/taxi industry, plus ambulance and ambulette services. "for-hire" auto classes through a network of producers comprised of commissioned sub-brokers, approved, appointed, and supported by ProTrans.

Headquarters Location

Manasquan, New Jersey,

United States



Latest ProTrans News

NextCell Pharma presents at Redeye Theme: Regenerative Medicine/Cell Therapy

Feb 14, 2024

NextCell Pharma AB Wed, Feb 14, 2024 09:15 CET Today Wednesday on February 14th at 10.30 CET Dr. Mathias Svahn, CEO of NextCell Pharma AB (“NextCell" or the"Company"), will present the latest developments in the company at Redeye. The presentation is live broadcasted and can be followed at Redeye Theme: Regenerative Medicine/Cell Therapy - Redeye where the replay and the presentations will be available afterwards. For more information about NextCell Pharma, please contact Mathias Svahn, CEO Sofie Falk Jansson, Head of Cellaviva Tel: +46 8 735 20 10 About NextCell Pharma AB NextCell is a cell therapy company in Phase 2 trials with the drug candidate ProTrans for the treatment of type 1 diabetes. The focus is to obtain market approval of ProTrans via a Phase 3 trial. In addition to type 1 diabetes, ProTrans is used in two clinical trials for COVID-19, in Örebro and in Montreal, Canada. Furthermore, NextCell owns 8.5% in FamicordTX, a CAR-T start-up in oncology, and 100% of Cellaviva, Scandinavia’s largest private stem cell bank licensed by the Swedish Health Authority (IVO) to preserve and store stem cells from umbilical cord blood and umbilical cord tissue for family use.

ProTrans Frequently Asked Questions (FAQ)

  • Where is ProTrans's headquarters?

    ProTrans's headquarters is located at Manasquan.

  • What is ProTrans's latest funding round?

    ProTrans's latest funding round is Merger.

  • Who are the investors of ProTrans?

    Investors of ProTrans include All Trans Risk Solutions.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.